These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 35688954)
21. Patient selection criteria for electrostimulation of salivary production in the treatment of xerostomia secondary to Sjogren's syndrome. Erlichman M Health Technol Assess Rep; 1990; (8):1-7. PubMed ID: 1369638 [TBL] [Abstract][Full Text] [Related]
22. Periodontitis, caries and salivary factors in Sjögren's syndrome patients compared to sex- and age-matched controls. Jorkjend L; Johansson A; Johansson AK; Bergenholtz A J Oral Rehabil; 2003 Apr; 30(4):369-78. PubMed ID: 12631160 [TBL] [Abstract][Full Text] [Related]
23. An update of the etiology and management of xerostomia. Porter SR; Scully C; Hegarty AM Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jan; 97(1):28-46. PubMed ID: 14716254 [TBL] [Abstract][Full Text] [Related]
24. [Usefulness of the saliva ferning test in diagnosis of Sjögren's syndrome]. Puszczewicz M; Zimmermann-Górska I; Białkowska-Puszczewicz G Pol Arch Med Wewn; 2002 Jan; 107(1):13-7. PubMed ID: 12046339 [TBL] [Abstract][Full Text] [Related]
25. Upper airway surface tension but not upper airway collapsibility is elevated in primary Sjögren's syndrome. Hilditch CJ; McEvoy RD; George KE; Thompson CC; Ryan MK; Rischmueller M; Catcheside PG Sleep; 2008 Mar; 31(3):367-74. PubMed ID: 18363313 [TBL] [Abstract][Full Text] [Related]
26. Significance and Implications of Patient-reported Xerostomia in Sjögren's Syndrome: Findings From the National Institutes of Health Cohort. Billings M; Dye BA; Iafolla T; Baer AN; Grisius M; Alevizos I EBioMedicine; 2016 Oct; 12():270-279. PubMed ID: 27639822 [TBL] [Abstract][Full Text] [Related]
27. Could the use of saliva substitutes improve food oral processing in individuals with xerostomia? A systematic review. Piaton S; Duconseille A; Roger-Leroi V; Hennequin M J Texture Stud; 2021 Jun; 52(3):278-293. PubMed ID: 33587294 [TBL] [Abstract][Full Text] [Related]
28. Effect of Saliment on parotid salivary gland secretion and on xerostomia caused by Sjögren's syndrome. Donatsky O; Johnsen T; Holmstrup P; Bertram U Scand J Dent Res; 1982 Apr; 90(2):157-62. PubMed ID: 7041242 [TBL] [Abstract][Full Text] [Related]
29. Oral health condition and saliva flow in southern Chinese with Sjögren's syndrome. Leung KC; McMillan AS; Leung WK; Wong MC; Lau CS; Mok TM Int Dent J; 2004 Jun; 54(3):159-65. PubMed ID: 15218897 [TBL] [Abstract][Full Text] [Related]
30. Use and efficacy of dry-mouth interventions in Sjögren's disease patients and possible association with perceived oral dryness and patients' discomfort. Assy Z; van Santen JS; Brand HS; Bikker FJ Clin Oral Investig; 2023 Sep; 27(9):5529-5537. PubMed ID: 37507599 [TBL] [Abstract][Full Text] [Related]
31. Meta-analysis on pharmacological therapies in the management of xerostomia in patients with Sjogren's syndrome. Garlapati K; Kammari A; Badam RK; B E S; Boringi M; Soni P Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):312-318. PubMed ID: 30932714 [No Abstract] [Full Text] [Related]
32. The association between oral dryness and use of dry-mouth interventions in Sjögren's syndrome patients. Assy Z; Bikker FJ; Picauly O; Brand HS Clin Oral Investig; 2022 Feb; 26(2):1465-1475. PubMed ID: 34374853 [TBL] [Abstract][Full Text] [Related]
33. Topical and systemic medications for the treatment of primary Sjögren's syndrome. Ramos-Casals M; Brito-Zerón P; Sisó-Almirall A; Bosch X; Tzioufas AG Nat Rev Rheumatol; 2012 May; 8(7):399-411. PubMed ID: 22549247 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren's syndrome: a double-blind placebo-controlled multicenter trial. Sugai S; Takahashi H; Ohta S; Nishinarita M; Takei M; Sawada S; Yamaji K; Oka H; Umehara H; Koni I; Sugiyama E; Nishiyama S; Kawakami A Mod Rheumatol; 2009; 19(2):114-24. PubMed ID: 19089532 [TBL] [Abstract][Full Text] [Related]
35. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome. Khurshudian AV Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025 [TBL] [Abstract][Full Text] [Related]
36. Lubricating properties of chewing stimulated whole saliva from patients suffering from xerostomia. Vinke J; Oude Elberink M; Stokman MA; Kroese FGM; Nazmi K; Bikker FJ; van der Mei HC; Vissink A; Sharma PK Clin Oral Investig; 2021 Jul; 25(7):4459-4469. PubMed ID: 33661446 [TBL] [Abstract][Full Text] [Related]
37. Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome. van der Reijden WA; Vissink A; Veerman EC; Amerongen AV Ann Rheum Dis; 1999 Aug; 58(8):465-74. PubMed ID: 10419864 [No Abstract] [Full Text] [Related]
38. Detection of xerostomia, Sicca, and Sjogren's syndromes in a national sample of adults. Stankeviciene I; Puriene A; Mieliauskaite D; Stangvaltaite-Mouhat L; Aleksejuniene J BMC Oral Health; 2021 Oct; 21(1):552. PubMed ID: 34706704 [TBL] [Abstract][Full Text] [Related]
39. Smell and Taste Function and Their Disturbances in Sjögren's Syndrome. Błochowiak K Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231772 [TBL] [Abstract][Full Text] [Related]
40. Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment. Komai K; Shiozawa K; Tanaka Y; Yoshihara R; Tanaka C; Sakai H; Yamane T; Murata M; Tsumiyama K; Hashiramoto A; Shiozawa S Mod Rheumatol; 2009; 19(4):416-9. PubMed ID: 19452244 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]